Tag Archives: Diseases

ATAI Life Sciences acquires majority stake in Perception Neuroscience to develop arketamine therapy for neuropsychiatric diseases

Munich and New York, 03 January 2019 – ATAI Life Sciences AG has acquired a majority stake in New York based Perception Neuroscience, a biopharmaceutical company focused on developing innovative therapies in neuropsychiatry. Perception was founded by Jonathan Sporn, MD, and Jay Kranzler, MD, PhD, both of whom have held multiple senior R&D leadership roles… Read More »

How Digital Health Technology Helps Fight Cardiovascular Diseases?

 “Use of digital health tools was shown to help patients expecting cardiac rehabilitation lost more weight and relieve themselves against those who lack such technological solutions.” Digital health strides in remote monitoring, smart applications and patient portals helps the industry professionals in treating cardiovascular disorders in a far more effective manner against the traditional technological… Read More »